Eriko Hamada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eriko Hamada has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Motoo Yamauchi
Nara Medical University
6 shared publications - Shigeo Muro
Department of Respiratory Medicine Nara Medical University Nara Japan
3 shared publications - Aiko Tanaka
Department of Anesthesiology and Intensive Care Medicine, Osaka University Graduate School of Medicine, Suita, Japan
1 shared publication Anne Sophie von Krogh
Department of Hematology St. Olavs Hospital, Trondheim University Hospital Trondheim Norway
1 shared publication- Azusa Ikegami
Sleep Center, Kuwamizu Hospital, 1-14-41 Kuwamizu, Chuo-ku, Kumamoto 862-0954, Japan
1 shared publication - Bernhard Lämmle
Center for Thrombosis and Hemostasis, University Medical Center Johannes Gutenberg University Mainz Germany
1 shared publication
Latest Publications
- 1 August 2025
- Published by Springer Nature
- p. 101-110
Implantable Therapy: What is the Position of Implantable Equipment in the Treatments for OSA?
- 1 August 2025
- Published by Springer Nature
- p. 101-110
Implantable Therapy: What is the Position of Implantable Equipment in the Treatments for OSA?
- 1 July 2025
- Published by Elsevier in Respiratory Investigation
- Vol. 63 (5) , 794-799
Clinical outcomes, safety, and potential prognostic factors of noninvasive respiratory support in patients with COVID-19: A Japanese multicenter observational study
- 1 July 2025
- Published by Elsevier in Respiratory Investigation
- Vol. 63 (5) , 794-799
Clinical outcomes, safety, and potential prognostic factors of noninvasive respiratory support in patients with COVID-19: A Japanese multicenter observational study
- Open Access
- 7 May 2025
- Published by MDPI AG in Surgical Techniques Development
- Vol. 14 (2) , 15
Bilateral Stylopharyngeus Transection Alters Respiratory Airflow in Conscious Rats
Background/Objectives: Upper airway patency is a key pathophysiological factor in obstructive sleep apnea (OSA). Research has primarily focused on the role of the genioglossus muscle in maintaining airway patency in OSA. However, hypoglossal nerve stimulation (HNS) therapy, which activates the genioglossus muscle, has been associated with poor outcomes in patients with lateral oropharyngeal collapse. The stylopharyngeus muscle is an upper airway dilator muscle that supports the lateral pharyngeal wall. Its role in maintaining upper airway patency and its effect on normal respiratory airflow is unclear. We hypothesize that bilateral transection of the stylopharyngeus muscles disrupts normal breathing. Currently, no animal model depicting lateral pharyngeal collapse has been reported. This study aims to introduce a novel rodent model with bilateral transection of the stylopharyngeus muscles to examine its effect on respiratory airflow and tracing. Methods: Adult male Sprague Dawley rats were divided into two groups: (1) bilateral stylopharyngeus muscle transection (n = 4) and (2) sham surgery (n = 2). Under anesthesia, the stylopharyngeus muscle was transected bilaterally in the transection group, while only exposure of the muscle was performed in the sham group. Respiratory airflow was measured using whole-body plethysmography before and after surgery, and airflow tracings were analyzed. Results: Significant alterations in respiratory airflow and tracings, particularly a flattening in inspiratory flow and sharp expiratory peaks, were observed on the first post-operative day in the transection group. The flattening of the inspiratory flow persisted over 3 days. No significant changes were noted in the sham group. Conclusions: Bilateral stylopharyngeus muscle transection alters normal airflow in a conscious rodent model, supporting the hypothesis that stylopharyngeus muscle plays a vital role in shaping respiratory airflow. The flattening of the inspiratory airflow is an indication of flow limitations through the upper airway patency due to the loss of stylopharyngeus function.
- 7 May 2025
- Published by MDPI AG in Surgical Techniques Development
- Vol. 14 (2) , 15
Open AccessBilateral Stylopharyngeus Transection Alters Respiratory Airflow in Conscious Rats
Background/Objectives: Upper airway patency is a key pathophysiological factor in obstructive sleep apnea (OSA). Research has primarily focused on the role of the genioglossus muscle in maintaining airway patency in OSA. However, hypoglossal nerve stimulation (HNS) therapy, which activates the genioglossus muscle, has been associated with poor outcomes in patients with lateral oropharyngeal collapse. The stylopharyngeus muscle is an upper airway dilator muscle that supports the lateral pharyngeal wall. Its role in maintaining upper airway patency and its effect on normal respiratory airflow is unclear. We hypothesize that bilateral transection of the stylopharyngeus muscles disrupts normal breathing. Currently, no animal model depicting lateral pharyngeal collapse has been reported. This study aims to introduce a novel rodent model with bilateral transection of the stylopharyngeus muscles to examine its effect on respiratory airflow and tracing. Methods: Adult male Sprague Dawley rats were divided into two groups: (1) bilateral stylopharyngeus muscle transection (n = 4) and (2) sham surgery (n = 2). Under anesthesia, the stylopharyngeus muscle was transected bilaterally in the transection group, while only exposure of the muscle was performed in the sham group. Respiratory airflow was measured using whole-body plethysmography before and after surgery, and airflow tracings were analyzed. Results: Significant alterations in respiratory airflow and tracings, particularly a flattening in inspiratory flow and sharp expiratory peaks, were observed on the first post-operative day in the transection group. The flattening of the inspiratory flow persisted over 3 days. No significant changes were noted in the sham group. Conclusions: Bilateral stylopharyngeus muscle transection alters normal airflow in a conscious rodent model, supporting the hypothesis that stylopharyngeus muscle plays a vital role in shaping respiratory airflow. The flattening of the inspiratory airflow is an indication of flow limitations through the upper airway patency due to the loss of stylopharyngeus function.
- 23 September 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 234, 107815
Evaluation of continuous positive airway pressure adherence and its contributing factors
- 23 September 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 234, 107815
Evaluation of continuous positive airway pressure adherence and its contributing factors
- Open Access
- 1 July 2024
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (5) , 1863-1865
Novel concept of personalized therapy with continuous positive airway pressure
- 1 July 2024
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (5) , 1863-1865
Open AccessNovel concept of personalized therapy with continuous positive airway pressure
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A2381
The Tolerance of Non Invasive Positive Pressure Ventilation in Patients with Myotonic Dystrophy
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A2381
The Tolerance of Non Invasive Positive Pressure Ventilation in Patients with Myotonic Dystrophy
- Open Access
- 18 November 2022
- Published by Wiley in Respirology Case Reports
- Vol. 10 (12) , e01065
Pulmonary sarcoidosis with a cavitary lesion in the lung caused by a TNF‐α inhibitor: A case report
A 28‐year‐old man with ankylosing spondylitis (AS) who was treated with a tumour necrosis factor‐alpha (TNF‐α) inhibitor, adalimumab, presented with newly detected multiple bilateral pulmonary nodules on chest computed tomography (CT). We suspected bacterial infection, including those caused by acid‐fast bacilli, or adalimumab‐related condition, such as sarcoidosis. After adalimumab cessation, no resolution of the pulmonary shadows was observed. Moreover, pulmonary cavitation appeared on chest CT at 7 weeks, prompting surgical lung biopsy. Acid‐fast bacteria culture of the lung tissue showed negative results. Pathological examination suggested that confluent granulomas associated with sarcoidosis might have obstructed the blood vessels, causing necrosis and lung cavitation. Consequently, prednisolone was initiated, and these shadows were reduced. After administering anti‐interleukin (IL)‐17A antibody for treatment of AS and prednisolone withdrawal, these shadows were not exacerbated. TNF‐α inhibitor‐induced sarcoidosis could cause cavitary lesions due to vascular invasion of granulomas.
- 18 November 2022
- Published by Wiley in Respirology Case Reports
- Vol. 10 (12) , e01065
Open AccessPulmonary sarcoidosis with a cavitary lesion in the lung caused by a TNF‐α inhibitor: A case report
A 28‐year‐old man with ankylosing spondylitis (AS) who was treated with a tumour necrosis factor‐alpha (TNF‐α) inhibitor, adalimumab, presented with newly detected multiple bilateral pulmonary nodules on chest computed tomography (CT). We suspected bacterial infection, including those caused by acid‐fast bacilli, or adalimumab‐related condition, such as sarcoidosis. After adalimumab cessation, no resolution of the pulmonary shadows was observed. Moreover, pulmonary cavitation appeared on chest CT at 7 weeks, prompting surgical lung biopsy. Acid‐fast bacteria culture of the lung tissue showed negative results. Pathological examination suggested that confluent granulomas associated with sarcoidosis might have obstructed the blood vessels, causing necrosis and lung cavitation. Consequently, prednisolone was initiated, and these shadows were reduced. After administering anti‐interleukin (IL)‐17A antibody for treatment of AS and prednisolone withdrawal, these shadows were not exacerbated. TNF‐α inhibitor‐induced sarcoidosis could cause cavitary lesions due to vascular invasion of granulomas.
- Open Access
- 21 October 2022
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (7) , e12814
Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection inrare disease
- 21 October 2022
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (7) , e12814
Open AccessHereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection inrare disease